Tularemia in Germany—A Re-emerging Zoonosis by Faber, Mirko et al.
REVIEW
published: 16 February 2018
doi: 10.3389/fcimb.2018.00040
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 1 February 2018 | Volume 8 | Article 40
Edited by:
Marina Santic,
University of Rijeka, Croatia
Reviewed by:
John S. Gunn,
The Ohio State University,
United States
Lee-Ann H. Allen,




Received: 24 November 2017
Accepted: 31 January 2018
Published: 16 February 2018
Citation:
Faber M, Heuner K, Jacob D and
Grunow R (2018) Tularemia in
Germany—A Re-emerging Zoonosis.




Mirko Faber 1, Klaus Heuner 2,3, Daniela Jacob 3 and Roland Grunow 3*
1Gastrointestinal Infections, Zoonoses and Tropical Infections (Division 35), Department for Infectious Disease Epidemiology,
Robert Koch Institute, Berlin, Germany, 2Working Group, Cellular Interactions of Bacterial Pathogens, Centre for Biological
Threats and Special Pathogens, Division 2 (ZBS 2), Robert Koch Institute, Berlin, Germany, 3Highly Pathogenic
Microorganisms, Centre for Biological Threats and Special Pathogens, Division 2 (ZBS 2), Robert Koch Institute, Berlin,
Germany
Tularemia, also known as “rabbit fever,” is a zoonosis caused by the facultative
intracellular, gram-negative bacterium Francisella tularensis. Infection occurs through
contact with infected animals (often hares), arthropod vectors (such as ticks or deer flies),
inhalation of contaminated dust or through contaminated food and water. In this review,
we would like to provide an overview of the current epidemiological situation in Germany
using published studies and case reports, an analysis of recent surveillance data and
our own experience from the laboratory diagnostics, and investigation of cases. While in
Germany tularemia is a rarely reported disease, there is evidence of recent re-emergence.
We also describe some peculiarities that were observed in Germany, such as a broad
genetic diversity, and a recently discovered new genus of Francisella and protracted or
severe clinical courses of infections with the subspecies holarctica. Because tularemia is a
zoonosis, we also touch upon the situation in the animal reservoir and one-health aspects
of this disease. Apparently, many pieces of the puzzle need to be found and put into place
before the complex interaction between wildlife, the environment and humans are fully
understood. Funding for investigations into rare diseases is scarce. Therefore, combining
efforts in several countries in the framework of international projects may be necessary
to advance further our understanding of this serious but also scientifically interesting
disease.
Keywords: Francisella tularensis, tularemia, epidemiology, case report, one health, Germany, ecology, veterinary
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INTRODUCTION
Germany represents a low incidence region with regard to tularemia in humans caused by
Francisella tularensis. We highlight some peculiarities of the pathogen as observed in Germany and
describe the epidemiology, outbreaks and possible sources of infection, different clinical courses
and aspects of diagnosis as well as underline the one-health aspect of tularemia considering this
disease relevant for human, animal, and environmental health. Tularemia in Germany is described
as an example for many other European countries with a similar epidemiological situation, and
parallels might be helpful to initiate further research on national and international levels.
Faber et al. Tularemia in Germany
THE PATHOGEN
Tularemia is caused by infection with the facultative intracellular,
gram-negative bacterium Francisella tularensis (Ellis et al., 2002;
Sjöstedt, 2011). The most clinically relevant subspecies are
F. tularensis ssp. holarctica distributed over the whole northern
hemisphere and the more virulent ssp. tularensis which is almost
exclusively found in North America and associated with lethal
pulmonary infections (Ellis et al., 2002). Further species or
subspecies of the genus Francisella have a low or unknown
pathogenicity for humans (e.g., F. tularensis ssp. novicida and
F. tularensis ssp. mediasiatica found in North America and
Asia, respectively) (Ellis et al., 2002; Kingry and Petersen,
2014; Challacombe et al., 2017). Only recently, the presence of
F. tularensis ssp. holarctica has been confirmed in the southern
hemisphere (Eden et al., 2017).
In Germany, F. tularensis ssp. holarctica is the only subspecies
known to cause disease in patients and animals. Only one other
Francisella species, Francisella sp. isolateW12-1067 isolated from
a water reservoir of a cooling tower of a hospital, has been
found in Germany (Rydzewski et al., 2014). This isolate is
∼89% identical to the chromosomal DNA of the published strain
F. guangzhouensis, indicating that there may be additional, yet
unidentified Francisella species present in Germany. Recently,
a Chinese group proposed a strain related to Francisella sp.
strain W12-1067 to represent a new genus called Allofrancisella
(Qu et al., 2016). However, the identification of new Francisella
species (Challacombe et al., 2017) and additional further research
will reveal whether the proposal of a new genus can be confirmed
and whether it is pathogenic for humans.
Studies on bacterial isolates from wild animals and humans
revealed an unexpectedly high genetic diversity of F. tularensis
ssp. holarctica in Germany (Gehringer et al., 2013; Müller
et al., 2013; Schulze et al., 2016). In a recent study the
phylogenetic analysis of isolates from wild animals from the
Berlin/Brandenburg region revealed three new subclades within
the phylogenetic tree, subclade B.71 from a raccoon dog
[Nyctereutes procyonoides], subclade B.74 from a red fox [Vulpes
vulpes] and subclade B.75 from an Eurasian beaver [Castor fiber
albicus] (Schulze et al., 2016). The genetic diversity is not only
of academic interest: In the phylogenetic analysis, erythromycin-
susceptible F. tularensis ssp. holarctica cluster with biovar I and
erythromycin-resistant with biovar II. While biovar I is mainly
found in Western Europe, biovar II occurs in Northern and
Eastern Europe (Kudelina, 1973; Ellis et al., 2002; Svensson
et al., 2009a; Vogler et al., 2009a,b; Karlsson et al., 2016). In
a recent study, 94 isolates were susceptible to erythromycin,
which defines biovar I (genotypes B.4 and B.6), while 34 were
resistant (biovar II; genotype B.12). Both Francisella biovars
are present in Germany (Tomaso et al., 2017). It is still under
debate whether strains of genotype B.6 may have a higher
pathogenic potential than strains belonging to the B.12 genotype
(Gyuranecz et al., 2010; Origgi and Pilo, 2016; Hestvik et al., 2017;
Kreizinger et al., 2017). There are further publications describing
the phylogeographic pattern of Francisella in Europe (Vogler
et al., 2009a; Gyuranecz et al., 2012; Karlsson et al., 2013; Origgi
et al., 2014; Thelaus et al., 2014; Dwibedi et al., 2016).
The high genetic diversity observed in F. tularensis isolates
suggests that additional Francisella pheno genotypes and remain
to be discovered. Germany might represent a “melting pot,” a
region where, within the postulated spread of the pathogen from
east to west, strains are mixed, re-assorted and give rise to further
variants with still unknown characteristics (Jusatz, 1952a, 1961;
Chanturia et al., 2011; Dwibedi et al., 2016). Phylogenetic studies
also revealed a spread of tularemia from Scandinavia to the south
of Europe (Karlsson et al., 2013; Dwibedi et al., 2016). More
research on phylogenetic relations and pathogenicity of specific
isolates is required for a better understanding of how genetics
correlates with environmental habitats, reservoirs, vectors, and
transmission routes.
OCCURRENCE OF TULAREMIA IN
GERMANY–PAST AND PRESENT
Historical publications describe the spread of tularemia from
Eastern Europe to Western Europe, crossing the German
geographical territory since the nineteenth century (Jusatz,
1952b). The cited early descriptions of tularemia assumed that
the disease was already known under names such as “epidemic
lymphadenitis,” “Plague-like lymphadenitis,” and “Influenza-like
disease of water hole hunters.” A verification of such historic
cases of lymphadenitis as tularemia would clarify the early
occurrence and distribution of the disease in Europe.
More information is available for the time following the
Second World War: a retrospective study revealed 687 cases
reported from 1949 to 2005 (Grunow and Priebe, 2007), 515 of
which were observed until 1959. This was attributed to the socio-
economic situation after the war. The incidence of tularemia
is known to increase during or after armed conflicts due to a
decline in hygiene, housing conditions and food safety. This was
also observed e.g., in Kosovo after the armed conflicts when
two outbreaks of tularemia occurred in 2000–2002 with more
than 500 confirmed cases in a region that had previously been
likely to be non-endemic (Grunow et al., 2012). The suspected
reason for these outbreaks was a strong increase in the population
of small rodents due to crops left on the field. Beginning with
the cold season, infected animals came in close contact with
human dwellings and contaminated accessible food storages and
unprotected drinking water sources. From 1960 to 2004, between
9 and 34 cases per 5-year intervals were reported in Germany,
indicating a very low incidence or poor reporting activity despite
the fact that tularemia was a notifiable disease in both East and
West Germany during this period (Grunow and Priebe, 2007).
Today, tularemia is a notifiable disease in Germany according
to the infection protection act of 2001. For surveillance purposes,
a case is defined as a person with symptoms and laboratory
confirmation of a recent F. tularensis infection, indicated by
at least one of the four following methods: Antigen detection
by e.g., enzyme immune assays or immunofluorescence assays;
isolation of the living pathogen by cultivation; detection of
specific nucleic acids, e.g., by polymerase chain reactions; or
detection of specific antibodies with an increase of the titer in
paired serum samples taken with a difference in time along the
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Between 1 January 2002 and 31 December 2016, n= 257 cases
of tularemia were notified in Germany (Figure 1), corresponding
to a mean yearly incidence of 0.03 cases per 100,000 population
(range: 0.00–0.05). In patients presenting with lymphadenitis and
fever, tularemia is rarely considered as a differential diagnosis
by clinicians and diagnostic laboratories, therefore it can be
assumed that tularemia is subject to significant underdiagnosis
and underreporting in Germany. Of the 257 cases reported, 217
were sporadic cases and 40 were part of case clusters. Age of the
patients ranged from 1 to 87 years (mean: 46) and the male to
female ratio was 2.06. While a median of three annual cases were
notified from 2002 through 2006, a continuous increase with a
maximum of 41 cases in 2016 was observed thereafter (Figure 1).
It is unclear whether this increase is due to an actual increase in
infection pressure and clinical cases or whether it is the result
of increased awareness and more frequent testing. However, a
relatively stable proportion of hospitalized cases suggests that
the increase is not the result of a change in sensitivity of the
surveillance system.
Tularemia is a clearly seasonal disease in Germany with
most patients (68%) reporting symptom onset from July through
November (Figure 2) when reservoir animal populations are
peaking and frequent outdoor activities (such as hunting,
farming, fishing, hiking etc.) facilitate contact between wildlife
and humans. This is in concordance with the seasonal occurrence
of tularemia cases in Europe (Hestvik et al., 2015). Imported
cases only account for a small fraction of the total case load
(28 of 227, 12.5%), peaking after the summer holiday season
in August and after Christmas/New Year. It is remarkable that
cases until and after 2001 were reported from almost all Federal
States of Germany. Between 2002 and 2016 the highest mean
annual incidences were recorded in parts of Saxony-Anhalt,
Baden-Württemberg and Brandenburg (Figure 3).
Although there is large variability in the regional incidence of
tularemia, long-term surveillance data indicate that the pathogen
can be found all-over Germany. The variation in the number
of reported cases from the different Federal States could be
explained by (i) variations in actual disease incidence as a result
of varying exposure risks or infection pressure or (ii) variations in
diagnostic consideration of tularemia and reporting activity due
to differences in awareness of health care workers for the disease.
Indeed, serological studies indicate that most infections are not
diagnosed and reported in Germany (Al Dahouk et al., 2003;
Jenzora et al., 2008; Kaysser et al., 2008; Splettstoesser et al., 2009;
Gehringer et al., 2013; Kuehn et al., 2013; Müller et al., 2013; Otto
et al., 2014). Two cross-sectional studies have shown a relatively
high seroprevalence; one population-representative study from
2004 with 6,617 sera and one study conducted in a small town
in Baden-Württemberg in 2009 with 2,416 sera revealed positive
results in 0.23% and 2.3% of the sera, respectively (Porsch-
Ozcürümez et al., 2004; Splettstoesser et al., 2009). Serological
studies in hunters as a putative population at high risk have
shown a seroprevalence of up to 1.7% (Jenzora et al., 2008).
It can be concluded that Francisella tularensis has been
endemic for centuries on the territory today known as Germany
and has a wide-spread distribution among wildlife. In humans
tularemia probably represents a re-emerging disease with a
high proportion of undiagnosed cases. Better awareness and
knowledge of the disease among health care personnel is required
for a timely diagnosis and treatment of cases. More research is
required for a better understanding of the burden of disease and
public health impact of tularemia in Germany.
OUTBREAKS IN HUMANS AND SOURCES
OF INFECTIONS
In Germany, outbreaks or clusters of tularemia occur rarely and
are defined as at least two cases with an epidemiological link (such
as a common source of exposure).
Between 2002 and 2016, 10 case clusters were reported.
Except for two with a connection to situations in other countries
and one large outbreak caused by grape must (unintentional
contamination), the remaining eight clusters consisted of 2–10
cases and were associated with contact to wild animals, five of
them in the context of hunting activities (Straube and Hess, 1986;
Hofstetter et al., 2006; Schätzle and Schwenk, 2008; Hauri et al.,
2010; Schubert et al., 2011; Kohlmann et al., 2014; Boone et al.,
2015; Borde et al., 2017).
Five of the above clusters were reported in connection with
consumption of or contact to infected hares. The largest one
occurred in 2005 with a total of 10 affected hunters participating
in a hare hunting event (Hofstetter et al., 2006; Hauri et al.,
2010). For cases that were not part of clusters, tick bites have
been suspected as the source of infection besides contact to hares
(Lübbert et al., 2009; Boone et al., 2015; Borde et al., 2017).
Indeed, prevalence studies in ticks in the south-west of Germany
revealed presence of Francisella in 8% of 916 investigated Ixodes
ricinus while Dermacentor species clustered with Francisella
endosymbionts (Gehringer et al., 2013).
TULAREMIA IN ANIMALS
Tularemia case clusters in humans are often preceded by
outbreaks in wildlife and detection of the pathogen in captured
animals (Mörner, 1992; Splettstoesser et al., 2009); therefore
much effort has been taken to describe the distribution of the
pathogen in relevant reservoir animals. A serological study in
various wildlife species in Brandenburg (the state surrounding
the German capital Berlin), revealed a total of 101/1,353 positive
sera (7.5%) in foxes (Vulpes vulpes), raccoon dogs (Nyctereutes
procyonoides) and wild boar (Sus scrofa) (Kuehn et al., 2013).
There is also serological evidence for Francisella infections in
zoo animals: One seroconversion was documented in a hippo
(Hippopotamus amphibious) between 2003 and 2004 (Kuehn
et al., 2013). Other serological and bacteriological studies
confirmed a high sero- and pathogen prevalence in wildlife
including hares in Germany (Al Dahouk et al., 2003; Müller et al.,
2013; Otto et al., 2014).
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3 February 2018 | Volume 8 | Article 40
Faber et al. Tularemia in Germany
FIGURE 1 | Notified cases of tularemia (sporadic and non-sporadic cases) by year of notification, Germany, 2002–2016.
FIGURE 2 | Notified cases of tularemia with and without travel history by month of disease onset, Germany, 2002–2016 (n = 207 with available information).
In a recent study, 3 out of 29 animals (10%) examined were
F. tularensis positive which was in good agreement with the
results mentioned above, and the presence of F. tularensis in
raccoon dogs and red foxes could be confirmed (Schulze et al.,
2016). Thus F. tularensis was isolated from animal species not
previously reported as natural hosts in Germany. In the case
of a beaver deceased from tularemia in Brandenburg, it could
be confirmed that animals with high bacterial load may act as
local amplifiers in Germany (Otto et al., 2015; Schulze et al.,
2016). qPCR analyses indicated that F. tularensis persisted in the
aquatic environment during one climatic season, but apparently
no longer (Schulze et al., 2016).
In 2004, an outbreak of tularemia occurred in semi-
free-living common marmosets (Callithrix jacchus)
(Mätz-Rensing et al., 2007). F. tularensis was identified as
the cause of a sudden die-off of 5 out of 62 animals. As
all animals had been born at the facility, the outbreak was
autochthonous meaning the source of infection was at the place
where it occurred (Splettstoesser et al., 2007). A subsequent
study in rodents in central Germany identified bank voles
(Myodes glareolus), water voles (Arvicola terrestris), field voles
(Microtus agrestis), common voles (Microtus arvalis) and yellow-
necked field mice (Apodemus flavicollis) as potential sources of
Francisella infections (Kaysser et al., 2008; Gyuranecz et al., 2011;
Gehringer et al., 2013). Classically known, but also previously
rather neglected animals like foxes could be an indicator for the
prevalence of the pathogen (Kuehn et al., 2013).
The conclusion from these observations is that Francisella is
widely present in the environment in Germany and that a wide
range of wild animals (such as hares and wild boars), but also
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FIGURE 3 | Mean annual incidence per 100,000 population (shading) and
total number (blue digits) of notified tularemia cases by district, Germany
2002–2016.
vectors (e.g., ticks as illustrated in the previous chapter) can be
sources of infections in humans.
More research is needed to understand better the
circumstances and mechanisms of a successful transmission
of the pathogen from animal to animal and to humans. The
main animal reservoir allowing the persistence and survival of
Francisella in the wild is still unknown. Further research on
this question is required. It would also be important to study
changes in the ecosystems including populations of rodents and
lagomorphs to understand better the impact of such changes on
the prevalence of the pathogens in the wild and the occurrence
of tularemia in humans.
DIAGNOSES AND CLINICAL ASPECTS OF
TULAREMIA
F. tularensis ssp. holarctica causes usually a relatively mild
form of tularemia in humans. The clinical manifestation of
tularemia depends on the entry route of the bacterium into
the organism and is defined by ulceroglandular or glandular
form, oropharyngeal form, ocularglandular form and respiratory
form (WHO Guidelines on Tularaemia, 2007)1. The primary
common symptoms are fever and enlarged lymph nodes. The
mean incubation time is 3–5 days with a range of 1–21 days.
In the case of complications like suppuration, pneumonia and
meningitis convalescence is often extended.
Among notified cases in Germany, the most frequent clinical
presentations were glandular and ulceroglandular tularemia
(Table 1). 7% of the patients presented with mixed forms and
14% could not be assigned (they typically only presented with
fever (+ symptoms less typical for tularemia)). The latter could
also represent typhoidal tularemia. Not all authors differentiate
between “intestinal” and “oropharyngeal” forms of tularemia
(WHO Guidelines on Tularaemia, 2007)1. When symptoms of
both forms were present, these are listed under “combination”
in Table 1. Collecting additional clinical details during routing
surveillance could be considered to allow for a more accurate
classification of cases.
Of the 257 cases of tularemia reported in 2002–2016, 39
(15.2%) were confirmed using an antigen assay, 175 (68.1%)
serologically, 35 (13.6%) by culture and 58 (22.6%) by PCR (some
cases were confirmed by a combination of methods). Median
time from the onset of symptoms until notification (which
typically occurs within 2 days of diagnosis) was 32 days (inter
quartile range: 20–56 days), indicating that diagnosis is often
delayed.
The laboratory diagnosis is often based on the detection of
specific serum antibodies and/or of the F. tularensis DNA in
clinical samples, but also in fixed and paraffin-embedded samples
usually available from the pathology (own experience) (Grunow
et al., 2000, 2001, 2014; Schmitt et al., 2005; Splettstoesser et al.,
2005; Svensson et al., 2009b; Vogler et al., 2009b; Seibold et al.,
2010; Jacob et al., 2011; Euler et al., 2012; Georgi et al., 2012; Sting
et al., 2013; Chaignat et al., 2014; Becker et al., 2016; Challacombe
et al., 2017). In addition, the isolation of the pathogen should
be aimed at during an early stage of the disease for antibiotic
sensitivity testing and further molecular-epidemiological
investigation. The isolation of the pathogen was rarely successful
when samples were obtained after initiation of an effective
antibiotic treatment. On the other hand, we have seen that blood
cultures taken early in the clinical course can lead to a successful
isolation of the bacteria. Importantly, in the case of positive blood
cultures with gram-negative bacteria, highly pathogenic bacterial
organisms with extremely low infectious doses like Brucella or
Francisella should be taken into consideration by the laboratory
personnel and all following procedures should be carried out
under appropriate biosafety conditions corresponding to BSL2 or
BSL3 requirements (Directive 2000/54/EC http://eur-lex.europa.
eu/legal-content/EN/TXT/?uri=CELEX:32000L0054). It should
be noted that no natural resistances against first-line antibiotics
have been described so far (Kudelina, 1973; Tomaso et al., 2005,
2017; Georgi et al., 2012; Karlsson et al., 2016). In Germany,
the “Working Group of Competence and Treatment Centers
for highly contagious and life-threatening diseases (STAKOB)”
has developed recommendations for an adequate treatment
1http://apps.who.int/iris/bitstream/10665/43793/1/9789241547376_eng.pdf, last
check February 2018.
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TABLE 1 | Notified tularemia cases with laboratory confirmation by clinical
presentation, Germany, 2002–2016 (n = 257).
Form N %
Glandular (lymphadenitis and not meeting
criteria for other forms)
81 32
Ulceroglandular (lymphadenitis + skin ulcer) 46 18
Pneumonic (dyspnea or pneumonia) 29 11
Intestinal (diarrhea, vomiting or abdominal pain) 22 9
Oropharyngeal (lymphadenitis + tonsillitis,
pharyngitis, stomatitis)
18 7
Oculoglandular (lymphadenitis + conjunctivitis) 3 1
Combination (meeting criteria of >1 form) 19 7
other (symptoms not meeting any of the above






Interestingly, we and others have diagnosed several tularemia
patients with or without serious complications but with a
prolonged time of recovery or even a recurrence of the disease
after apparently adequate antibiotic treatment (Boone et al.,
2015) (see case series below).
Case 1: We have reported a tularemia case in Germany who
experienced a protracted clinical course over about 10 months
(Grunow et al., 2015). The patient, a 22-year-old female, was
living in an area in Germany where human cases of tularemia
have been detected previously. The clinical history indicated
a tick bite on the leg in June 2014. No further clinical signs
occurred. In August 2014, the patient visited Turkey without any
hints for an exposure risk. In mid-October, the patient became
ill with fever and she also noted a vesiculo-papular rash. After
treatment with ciprofloxacin over 5 days due to a simultaneous
urinary tract infection, the patient recovered and was well. Early
in December 2014, the patient experienced a unilateral cervical
lymph node enlargement without other clinical symptoms and
risk for exposure to Francisella tularensis. In mid-January
2015, the patient was hospitalized for further investigation.
The Magnetic resonance imaging revealed an inflammatory
liquefying lymph node on the right side and a lymphadenitis
on the left sight of the cervix. A lymph node extirpation was
conducted and the biopsy of the enlarged lymph node revealed
an abscess-forming granulomatous inflammationwith giant cells.
A tissue sample was tested positive for F. tularensis by 16S-
rPCR and the markers tul4 and fopA confirmed F. tularensis.
The RD1-PCR identified subspecies holarctica. Isolation of the
living pathogen was not successful. The patient was empirically
treated with cefuroxime and metronidazole. She remained sub-
febrile (37.3◦C). After the diagnosis of tularemia the treatment
was switched to oral doxycycline but the temperature did not
decline. A further treatment with ciprofloxacin p.o. over 14 d
cured the sub-febrile temperature. In February 2015, the patient
was in good general condition without fever, but still showed
unilaterally enlarged lymph nodes and thickening of the cervical
muscles, both painful on palpation. The site of the lymph node
extirpation showed signs of delayed healing with secretion of
a clear fluid (negative for F. tularensis). The vesiculo-papular
exanthema in the cervical region and in the face was still visible.
The serology at this time revealed an anti-Francisella titer of
>100,000 by ELISA and a positive Western blot. After several
ambulant controls, the patient was again hospitalized in March
2015 for further treatment with intravenous ciprofloxacin over
4 days and, after discharge from the hospital, further treatment
with oral ciprofloxacin for an additional 11 days. In April 2015,
out-patient control revealed secondary wound healing, good
general condition, no fever and no enlarged lymph nodes.
Case 2: Another 68-year-old patient was described by H.L.
Stich with a probable tick bite without cutaneous efflorescence
and a time to diagnosis of about 8 weeks (Robert Koch-
Institut, 2015). Because of a previously known neurological
symptomatology, a neuro-somatic reason for the initial fever
was assumed. After exclusion of this assumption, a detailed
anamnesis including occupational information revealed that the
patient had been a farmer for years and was also a hunter.
This led to the assumption of a zoonotic infectious disease. The
only sign of an infection was an elevated C-reactive protein
(29.1 mg/l). Brucellosis and Q-fever were serologically excluded.
Only 3 weeks after the first hospitalization, F. tularensis was
considered and a clearly elevated antibody titer was detected.
After this diagnosis, a specific treatment with doxycycline was
initiated. The patient was discharged from the hospital after 4
weeks of therapy. Furthermore, it was revealed that 1 year before,
four field hares infected with F. tularensis had been detected.
This case shows that the consideration of differential diagnoses
of tularemia might be hampered by other dominant clinical
manifestations. In the case of pulmonary tularemia, lung cancer
or tuberculosis are often the first choice of diagnoses. However,
in the case of unclear fever and anamnestic information pointing
toward contact with wild animals, tularemia should always be
taken into diagnostic consideration.
Case 3: We described another 20-year-old female patient
with a tick bite in her right hand occurring 5 months before
consultation, followed by fever, chills and regional painful axillary
lymphadenopathy (Lübbert et al., 2009). Interestingly, the
empiric antibiotic treatment with doxycycline and ciprofloxacin
had led to defervescence but no change in painful lymph
node swelling. Surgical removal of a cubital lymph node was
performed 3 months after the tick bite. 5 months after the
tick bite laboratory findings were normal except for moderate
elevation of C-reactive protein. Detection of specific serum
antibodies against F. tularensis confirmed the suspected clinical
diagnosis of ulceroglandular tularemia. The pathogen could
not be detected by isolation or PCR. The histology of the
removed painful axillary lymph node showed reticulocytic,
abscess-forming lymphadenitis with a pseudotuberculosis type
of granulomatosis and negative acid-fast staining. A complete
recovery was achieved without renewed antibiotic treatment.
In 2016/2017 we have seen several additional cases with
some peculiarities. An outbreak of tularemia with 6 serologically
confirmed cases among 30 mostly volunteering participants
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of a grape harvest in Rhineland-Palatinate which took place
at the beginning of October 2016 was reported to ProMED
(http://www.promedmail.org/post/4647937). 3–8 days after
the activity, the affected individuals developed symptoms like
high fevers, general malaise, and unilateral marked cervical
lymphadenopathy suggesting an oropharyngeal route of
infection. Interestingly, one patient showed symptoms of an oro-
pharyngeal tularemia only 24 days after the exposure. Another
patient experienced a severe clinical course of more than 2.5
months. Due to the absence of additional epidemiological
hinds, the diagnosis of tularemia was delayed. Three of the
six patients were briefly hospitalized. An epidemiological
outbreak investigation was initiated considering a broad range of
environmental exposures and food-stuffs consumed during the
event; the results have not been published yet.
The conclusion from these case reports is that F. tularensis
ssp. holarctica can cause long-lasting clinical courses of disease.
Tularemia can also occur as a recurrent disease over several
months. In addition, the onset of an oro-pharyngeal tularemia
can occur as late as 3 weeks after a relevant exposure. The
pathologic mechanisms of a protracted course of tularemia are
still unclear but an immune reaction to persistent antigens or
pathogens appears a plausible explanation (Straube and Hess,
1986; Hanke et al., 2009; Lübbert et al., 2009; Capka et al., 2010;
Dlugaiczyk et al., 2010; Fritzsch and Splettstoesser, 2010; Hauri
et al., 2010; Potz-Biedermann et al., 2011; Bulut et al., 2013;
Weile et al., 2013; Kohlmann et al., 2014; Guerpillon et al., 2016).
The infection route often remains unclear and can be suggested
only by a detailed anamnestic investigation. In late stages of
the disease, especially after appropriate antibiotic treatment,
living Francisella cannot be detected, but PCR investigation of
tissue material and serology confirms the disease. Awareness of
clinicians should be raised to consider tularemia in patients with
enlarged lymph nodes and fever and a relevant exposure. This
is even more important when atypical or very seldom clinical
manifestations are seen like in pneumonic tularemia with lung
nodules suggestive of malignancy, manifestation with uveitis or
endocarditis (Terrada et al., 2016; Gaci et al., 2017; Odegaard
et al., 2017).
ONE-HEALTH ASPECT OF TULAREMIA
Tularemia is a zoonotic disease. Cases of disease in humans and
animals are notifiable in Germany and several other European
countries. To understand the complexity of the disease, a close
cooperation of veterinary medicine, human medicine, animal
health and public health is crucial. Elevated risks of exposure
or even outbreaks in humans are often preceded by observation
of the disease in animals (Mörner, 1992; Splettstoesser et al.,
2007, 2009; Gyuranecz et al., 2011; Grunow et al., 2012; Kuehn
et al., 2013; Otto et al., 2014, 2015; Hestvik et al., 2015). Thus, a
timely sharing of data concerning cases in animals with the public
or the public health sector and awareness raising in outbreak
situations could facilitate the early detection or prevention of
cases in humans. The source of infection for human cases with
tularemia often cannot be identified; however, in several cases,
clues for an infection can be obtained through the anamnesis.
In very rare cases the source of infection can be verified. If
not eliminated, the sources of infection can pose a high risk to
other people. This can include e.g., drinking water contaminated
by dead animals, freshly pressed juice from field fruits, fresh
or frozen stored meat from infected animals. Unless direct
identification of the infectious sources is done, transmission
of bacteria by aerosols and dust, e.g., when cleaning barns or
cutting grass could become a continuing event. As insect vectors
can also transmit Francisella, knowledge of the prevalence in
ticks, mosquitoes and possibly other insects is of interest. The
investigation into sources of infection in sporadic cases and
outbreaks and also the investigation of the prevalence of the
pathogen in animals and environmental samples require a strong
one-health approach in which specialists of animal health and
of human health work together. This requires staff and financial
resources which are often scarce. Compared to other infectious
diseases, tularemia is rare and the burden of disease is relatively
low. Thus, funders and decision makers are hesitant to allocate
resources required to understand better the epidemiology of
this disease and to prevent further cases. While the disease
is rare, surveillance of human cases indicates a re-emergence
with an approximately ten-fold increase of notified cases in
Germany in a period of 15 years. Possible reasons include an
increased presence of the pathogen in the environment and more
frequent contact between humans and wildlife through leisure
activities. However, an increased awareness of the disease and
more frequent testing might have contributed to the continuous
rise of notified cases.
Interactions between pathogen, the environment, its hosts and
humans, render this interesting and potentially serious infectious
disease a complex topic. In case of rare diseases like tularemia,
utilizing international synergies, data, and expertise, ideally in
internationally sponsored research projects, seems important to
further advance prevention and control.
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